Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Salim Ivomas Pratama Tbk. (SIMP)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Salim Ivomas Pratama Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Salim Ivomas Pratama Tbk. diperdagangkan di Rp615 (kapitalisasi pasar 9,61 T, volume 24 jam 18,49 jt). Perbedaan utamanya: Salim Ivomas Pratama Tbk. jauh lebih besar — sekitar 92× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SIMP | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 9,61 T |
Volume | — | 18,49 jt |
Lot | — | 184,87 rb |
Perputaran | — | 11,38 M |
Harga Rata-rata | — | 615,52 |
Nilai Transaksi | — | 11,38 M |
Harga Ekuilibrium Indikatif | — | 615 |
Volume Ekuilibrium Indikatif | — | 2,65 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Salim Ivomas Pratama Tbk.
PT Salim Ivomas Pratama Tbk (the company) was established under its original name of PT Ivomas Pratama base on notarial deed No.65 of Mrs Maria Kidarsa, S.H, dated on 12 Aug, 1992. The Company’s articles of association has been amended several times, most recently by notarial deed No. 46 of Benny Kristianto, S.H., dated Dec 14, 2010, concerning among others, the change in the Company’s name, par value and public offering.
Selengkapnya di halaman SIMP →
